Kamada enrols first subject in Cytogam trial for CMV infection

The controlled multi-centre, randomised, prospective trial is investigating the therapy in kidney transplant recipients.

Kamada Announces First Patient Enrolled into an Investigator-Initiated Clinical Trial of CYTOGAM® to Prevent Cytomegalovirus in Kidney Transplantation

The study, titled “ Strategic Help with Immunoglobulin to Enhance protection against Late Disease (CMV) ” or SHIELD, is a prospective, randomized, controlled multicenter investigator-initiated study ...

Light-based tool continuously monitors vaccine quality during production

The outbreak of the COVID-19 pandemic demonstrated the need to rapidly develop, produce and distribute large quantities of ...

Moderna Announces Phase 3 Study of Investigational Cytomegalovirus (CMV) Vaccine Did Not Meet Primary Efficacy Endpoint

Company to discontinue development of mRNA-1647 in congenital CMV Company will continue to evaluate mRNA-1647 in ongoing ...

Common viral infections like flu and shingles can raise your risk of heart attack and stroke, analysis finds

Covid-19 infections have been strongly linked with cardiovascular events like a heart disease and stroke, but new research ...
Brainerd Dispatch

June is congenital Cytomegalovirus Awareness Month

BRAINERD — June is congenital Cytomegalovirus Awareness Month and Crow Wing County Public Health reported important news for Minnesota families — the Minnesota Department of Health has added ...
AZoLifeSciences on MSN

Light-Based Sensor Continuously Detects Vaccine Quality

A group of researchers from Purdue University and Merck & Co. Inc., referred to as Merck Sharp & Dohme Corp. in regions outside the U.S. and Canada, has recently unveiled a novel analytical tool that ...